Description
Assess and treat individuals with substance use disorders and co-occurring mental health issues. Provide individual and group counseling, treatment planning, relapse prevention, crisis intervention, case management, family education, and recovery support.
- Provide individual and group counseling for substance use and co-occurring disorders.
- Coordinate care with physicians, nurses, psychiatrists, and peer staff, including medication-assisted treatment (MAT).
- Conduct intake screenings and biopsychosocial assessments using DSM-5/ASAM criteria.
- Develop individualized, measurable treatment plans using evidence-based practices.
- Monitor and document client progress and outcomes per agency and regulatory standards.
- Facilitate relapse-prevention, psychoeducation, and recovery skills groups.
- Provide crisis intervention and safety planning; arrange higher levels of care when needed.
- Refer clients to detox, medication-assisted treatment (MAT), residential, outpatient, housing, and other resources; follow up on service efficacy.
- Educate and counsel families to support recovery and reduce stigma.
- Revise treatment and recovery plans based on progress or changes in level-of-care needs.
- Assist clients with appointments, transportation, and aftercare coordination to support adherence.
- Maintain confidentiality and documentation compliance (HIPAA, 42 CFR Part 2).
- Engage in professional development through supervision and continuing education.
Related specializations
Interview options
Interview options
Available on paid plans only
Interview timeRelated Pathways
Source
- Tasks & skills: O*NET occupational data (work activities, skills, knowledge). Learn more
- Sources & Standards: This site includes information from O*NET by the U.S. Department of Labor, Employment and Training Administration (USDOL/ETA), used under the CC BY 4.0 license. Career Clutch has modified some of this information for student readability. USDOL/ETA has not approved, endorsed, or tested these modifications. O*NET® is a trademark of USDOL/ETA.
Last reviewed: Jan 2026